⏱️ RSI in 60 seconds
- Team brief: roles, Plan A–D said aloud
- SOAP-ME kit: suction, O₂, airway, drugs, monitoring, equipment
- 2 working IVs (or IO)
- Mark cricothyroid membrane if difficult
- ≥3 min tidal breathing, 100% O₂
- Nasal cannula 15 L/min left on (apnoeic O₂)
- Hypoxaemic → NIV/BVM + PEEP
- Target EtO₂ ≥ 0.9 if measurable
- SBP ≥ 90 / MAP ≥ 65 before induction
- Shock index ≥ 0.9 → high risk
- Pressor connected or push-dose ready
- Reduce induction dose, not paralytic
- Ear-to-sternal-notch, face plane horizontal
- Head-up 20–30° (ramp if obese)
- Manual in-line stabilisation if C-spine risk
- Induction agent → immediately paralytic
- Flush each; start timer
- Gentle BVM with PEEP if desaturating
- Videolaryngoscope first
- Bougie or stylet ready
- Max 3 attempts (+1 by most experienced)
- SpO₂ falling → stop, reoxygenate
- Waveform capnography — sustained trace
- No trace = wrong place → remove
- Bilateral chest rise & air entry
- Analgesia + sedation now
- Secure tube, note depth, CXR
- Ventilator 6–8 mL/kg PBW
- Recheck BP every 2–3 min
Standard adult doses (use the calculator for mg)
🧮 Drug dose calculator
Enter the weight. Doses update automatically and show the mg/kg used. Optional height and sex give obesity dosing weights (adults).
1Pre-intubation assessment & preparation
Indications
- Failure to maintain or protect the airway — obstruction, loss of protective reflexes, uncontrolled secretions or blood.
- Failure of oxygenation or ventilation despite non-invasive support.
- Anticipated clinical course — airway burns, expanding neck haematoma, angioedema, deteriorating patient needing transfer, severe agitation preventing life-saving care.
A low GCS alone is not an absolute indication; judge airway protection, trajectory and need for imaging or transfer.
Contraindications / relative contraindications to RSI
- Predicted difficult airway where paralysis could create a "can't intubate, can't oxygenate" situation — consider awake technique or double set-up.
- Severe upper-airway obstruction (e.g. tumour, epiglottitis, deep neck infection) — senior anaesthesia/ENT, awake or theatre-based approach.
- Major facial/laryngeal trauma or disrupted anatomy — prepare primary front-of-neck access.
- Crash airway (cardiac arrest, agonal) — no induction drugs needed; intubate immediately.
- Contraindications to individual drugs (see Sections 3–4).
Airway assessment — difficult-airway predictors
| Difficulty | Mnemonic | Predictors |
|---|---|---|
| Laryngoscopy | LEMON | Look (trauma, beard, large tongue) · Evaluate 3-3-2 · Mallampati · Obstruction / obesity · Neck mobility |
| Bag-mask ventilation | ROMAN | Radiation / restriction · Obstruction / obesity / OSA · Mask seal (beard, edentulous) · Age >55 · No teeth |
| Supraglottic airway | RODS | Restricted mouth opening · Obstruction · Disrupted / distorted airway · Stiff lungs or C-spine |
| Front-of-neck access | SMART | Surgery · Mass · Access / anatomy (obesity) · Radiation · Tumour |
Physiological assessment — "physiologically difficult airway"
- Hypotension — SBP <90, MAP <65, or shock index (HR/SBP) ≥ 0.9.
- Hypoxaemia — SpO₂ <93% despite oxygen; expect rapid desaturation.
- Severe metabolic acidosis — apnoea and under-ventilation can cause a rapid pH fall and arrest. Match pre-intubation minute ventilation.
- Right ventricular failure — hypoxia, hypercapnia and positive pressure can precipitate collapse.
Preparation & equipment checklist (SOAP-ME)
- Suction — Yankauer on and under the pillow; second suction for massive soiling (consider SALAD technique).
- Oxygen — NRB, nasal cannula at 15 L/min, BVM with PEEP valve 5–10 cmH₂O, HFNO/NIV if needed.
- Airway — videolaryngoscope + direct laryngoscope, 2 tube sizes (adult female 7.0, male 7.5–8.0), stylet, bougie, 10 mL syringe, tie, OPA/NPA, 2nd-generation SGA, scalpel–bougie–tube kit (size 10 blade, bougie, 6.0 cuffed tube).
- Pharmacology — induction, paralytic, post-intubation sedation, push-dose and infusion vasopressor; all labelled.
- Monitoring — ECG, SpO₂, NIBP cycling every 2–3 min (arterial line if time and indicated), waveform capnography connected before induction.
- Equipment — ventilator checked, ETT holder, gastric tube, sugammadex available if using rocuronium.
Apnoeic oxygenation
Leave nasal cannula at 15 L/min (or HFNO 60–70 L/min) on from preoxygenation through laryngoscopy. It prolongs safe apnoea time, especially in obese and critically ill patients. Current airway-society guidance recommends oxygen delivery throughout airway management.
Haemodynamic optimisation before induction
- Target SBP ≥ 90 mmHg / MAP ≥ 65 before induction where possible ("resuscitate before you intubate").
- Fluid bolus only if hypovolaemic or fluid-responsive; routine boluses have not been shown to prevent collapse in trial data.
- Start a norepinephrine infusion (peripheral is acceptable short term via a good proximal cannula) or have push-dose pressor drawn up.
- Reduce the induction dose; keep the paralytic dose full.
When to consider awake intubation or an alternative strategy
- Predicted difficult laryngoscopy and difficult rescue oxygenation (BMV/SGA), when the patient is cooperative and time allows.
- Options: awake flexible bronchoscopic or awake videolaryngoscopic intubation with topical lidocaine (keep the total topical lidocaine within local maximum (commonly cited as ≤9 mg/kg lean body weight) and light sedation (e.g. ketamine, dexmedetomidine, remifentanil).
- "Double set-up": RSI with neck marked and scalpel kit open, surgeon/anaesthetist present.
- Upper-airway obstruction: call anaesthesia and ENT early; consider theatre.
2Preoxygenation
| Method | Settings | Use when | Notes |
|---|---|---|---|
| Standard face mask | 5–10 L/min | Not adequate for RSI | FiO₂ ~0.4–0.6. |
| Non-rebreather mask | 15 L/min → flush rate (O₂ flowmeter fully open) | Default if SpO₂ normal | Standard 15 L/min gives FiO₂ ~0.6–0.7; flush rate improves it. |
| Nasal cannula | 15 L/min (add under mask) | All RSIs — apnoeic oxygenation | Keep on through laryngoscopy. |
| High-flow nasal oxygen | 40–70 L/min, FiO₂ 1.0 | Anticipated difficult airway; mild–moderate hypoxaemia; apnoeic O₂ | Less effective than NIV in severe hypoxaemia. |
| BVM + PEEP valve | 15 L/min + flush, PEEP 5–15 cmH₂O, tight 2-hand seal | Hypoxaemia when NIV unavailable | Needs a one-way exhalation valve and good seal to deliver high FiO₂. |
| Non-invasive ventilation | FiO₂ 1.0, EPAP 5–8, IPAP 10–15 cmH₂O, ≥ 3 min | Hypoxaemic patients (e.g. SpO₂ <93% on NRB, PaO₂/FiO₂ <200) | Trial data: hypoxaemia roughly halved compared with mask preoxygenation (9.1% vs 18.5%), with no increase in aspiration. |
Special considerations
- Critically ill / shunt physiology: NRB may not raise SpO₂ — escalate early to NIV or BVM with PEEP. Current critical-care guidance suggests NIV over HFNO when PaO₂/FiO₂ <200.
- Obese: head-up 25–30° or reverse Trendelenburg, NIV/CPAP, apnoeic oxygenation. Desaturation is rapid.
- Agitated / unable to tolerate: ketamine 1 mg/kg IV (then 0.5 mg/kg increments) to allow preoxygenation before giving the paralytic (delayed sequence intubation). Have airway kit ready — some patients become apnoeic.
- Between induction and laryngoscopy: gentle BVM (≤ 20 cmH₂O, PEEP valve) reduces severe hypoxaemia, per trial data.
3Induction drugs
| Drug | Dose (mg/kg) | Typical adult (70 kg) | Onset | Duration | Advantages | Adverse effects | Contraindications / cautions |
|---|---|---|---|---|---|---|---|
| Ketamine | 1–2 Shock 0.5–1 | 100–150 mg | 30–60 s | 10–20 min | Maintains airway reflexes and respiratory drive; bronchodilator; sympathomimetic — usually preserves BP | Hypertension, tachycardia; hypotension/myocardial depression when catecholamine-depleted; emergence reactions; secretions; rarely laryngospasm | Uncontrolled severe hypertension, aortic dissection, active ACS (relative). Concern about raised ICP is not supported by current evidence. |
| Etomidate | 0.3 Shock 0.15–0.2 | 20 mg | 30–60 s | 3–10 min | Most haemodynamically neutral; rapid, predictable | Transient adrenal suppression (single dose, up to ~24 h); myoclonus; injection pain; nausea/vomiting | Septic shock: adrenal concern debated — large trial data showed no mortality difference vs ketamine. No analgesia. Availability varies by country. |
| Propofol | 1–2.5 Elderly 0.5–1.5Shock: avoid / 0.5 | 100–150 mg (healthy) | 15–45 s | 5–10 min | Bronchodilation; anticonvulsant; lowers ICP; smooth induction | Dose-dependent hypotension (vasodilation, myocardial depression); apnoea; injection pain | Shock, hypovolaemia, fixed cardiac output. Egg/soy allergy is generally not a true contraindication. |
| Midazolam | 0.1–0.3 | 5–15 mg | 60–120 s | 15–30 min | Widely available; anticonvulsant | Hypotension; slow onset prolongs apnoea before ideal conditions | Not preferred for RSI (slow, unpredictable). Still listed as an acceptable option in current critical-care guidance. |
- Shock / SI ≥ 0.9: reduce induction dose by about 50% (ketamine 0.5–1 mg/kg; etomidate 0.15–0.2 mg/kg); avoid propofol or use ≤0.5 mg/kg. Onset is slower — wait.
- Elderly / frail: reduce by 30–50%; titrate.
- Obesity: induction agents are generally dosed on lean body weight (propofol best studied). Using total body weight risks hypotension; using ideal body weight risks under-dosing and awareness. Sources vary — see Section 11.
- Never reduce the paralytic dose in shock — slower circulation delays onset; use rocuronium 1.2–1.6 mg/kg.
4Paralytics (neuromuscular blocking agents)
| Drug | RSI dose | Onset | Duration | Contraindications | Adverse effects | Special considerations |
|---|---|---|---|---|---|---|
| Rocuronium | 1.2 mg/kg range 1–1.6; 70 kg ≈ 84 mg | 45–60 s | 45–70 min (dose-dependent; longer in elderly and liver disease) | Known hypersensitivity | Anaphylaxis (uncommon but notable); prolonged block | No hyperkalaemia; preferred when succinylcholine is contraindicated. Reversal: sugammadex 16 mg/kg for immediate reversal — but do not rely on it to rescue a CICO situation, per current airway-society guidance. Long duration makes prompt post-intubation sedation essential (awareness risk). |
| Succinylcholine (suxamethonium) | 1.5 mg/kg range 1–2; 70 kg ≈ 105 mg; many protocols cap at 200 mg. IM 3–4 mg/kg (max 150 mg) | 30–60 s | 6–10 min | See red box below | Hyperkalaemia; bradycardia (repeat doses, children); fasciculations, myalgia; masseter spasm; trigger for malignant hyperthermia; prolonged block in pseudocholinesterase deficiency | Short duration does not mean the patient will breathe again before critical desaturation. Normal K⁺ rise ~0.5 mmol/L. |
- Personal or family history of malignant hyperthermia.
- Known or suspected hyperkalaemia (e.g. K⁺ ≥ 5.5, renal failure with unknown K⁺, ECG changes of hyperkalaemia, rhabdomyolysis).
- Up-regulated receptors (risk of fatal hyperkalaemia): major burns, crush injury or multiple trauma, denervation (stroke, spinal cord injury), prolonged immobilisation or critical illness — generally considered safe in the first ~24 h after injury; avoid after that. Risk peaks at 7–10 days and can persist for months. Time cut-offs vary between sources (24–72 h).
- Neuromuscular disease / myopathies: muscular dystrophies (Duchenne, Becker), myotonia, ALS, Guillain–Barré, multiple sclerosis with weakness.
- Known pseudocholinesterase deficiency (prolonged paralysis) — relative.
5RSI drug selection — which induction agent?
| Situation | Reasonable options | Clinical reasoning |
|---|---|---|
| Hypotension / shock | Ketamine 0.5–1 mg/kg or etomidate 0.15–0.2 mg/kg; rocuronium full dose | Both acceptable at reduced dose. Ketamine may still drop BP in catecholamine-depleted patients; etomidate is the most haemodynamically neutral. Avoid propofol. Pressor running or drawn up before induction. |
| Severe asthma | Ketamine 1–2 mg/kg (preferred by many); propofol if haemodynamically stable | Ketamine bronchodilates and preserves BP. Propofol also bronchodilates but causes hypotension, worsened by dynamic hyperinflation after intubation. |
| Raised ICP / TBI | Ketamine or etomidate; propofol only if BP robust | The priority is avoiding hypotension and hypoxia, which worsen outcome. Ketamine does not meaningfully raise ICP in ventilated patients and maintains cerebral perfusion. Propofol lowers ICP but risks hypotension. Lidocaine pretreatment is not supported by evidence. |
| Sepsis | Ketamine or etomidate at reduced dose | About half of the patients in that same trial had sepsis, with no mortality difference. Etomidate's adrenal suppression is real but transient; outcome harm is unproven. Expect peri-intubation hypotension. |
| Cardiovascular instability (cardiogenic shock, ACS, RV failure, severe aortic stenosis) | Etomidate 0.15–0.2 mg/kg often chosen; low-dose ketamine acceptable | Etomidate avoids sympathetic surge; ketamine raises myocardial O₂ demand. Avoid propofol. RV failure: avoid hypoxia and hypercapnia; minimise PEEP and tidal volume after intubation; norepinephrine ± vasopressin ready. |
| Agitated / hypoxic | Ketamine 1 mg/kg (then 0.5 mg/kg) for delayed sequence, then paralytic | Dissociation allows effective preoxygenation (current critical-care guidance suggests ketamine for this). Give the paralytic only after preoxygenation is optimised. |
| Severe bronchospasm (e.g. anaphylaxis, COPD) | Ketamine; propofol if stable. In anaphylaxis treat with IM/IV epinephrine first | Ketamine bronchodilates. Avoid histamine-releasing drugs (e.g. morphine, atracurium). Use the largest tube possible. |
6Immediately after tube placement
- Confirm: waveform ETCO₂ + bilateral chest rise and air entry; no epigastric sounds.
- Check depth: typical adult at the teeth ~21 cm (female), ~23 cm (male). Cuff pressure 20–30 cmH₂O.
- Secure the ETT with a tie or holder; record depth. Avoid tight ties that compress neck veins in TBI.
- Connect the ventilator (Section 9) and recheck ETCO₂, SpO₂ and peak/plateau pressures.
- Start analgesia and sedation now (Section 7). Succinylcholine wears off in ~6–10 min; rocuronium lasts about an hour, so the patient may be paralysed and aware.
- BP every 2–3 min for 15 min; treat hypotension (Section 8).
- Chest X-ray: tip 3–5 cm above carina (roughly T2–T4); check for pneumothorax and lines. Insert a gastric tube.
- Blood gas at 15–30 min; adjust ventilation.
7Post-intubation analgesia & sedation
| Drug | Loading / initial dose | Infusion | Onset | Duration (bolus) | Major adverse effects | Cautions |
|---|---|---|---|---|---|---|
| Fentanyl | 0.5–1 mcg/kg (25–100 mcg) | 0.5–2 mcg/kg/h (25–200 mcg/h) | 1–2 min | 30–60 min | Respiratory depression, chest wall rigidity (large fast boluses), mild hypotension | Analgesia first. Accumulates with prolonged infusion. Halve the bolus in shock. |
| Morphine | 2–5 mg (0.05–0.1 mg/kg) | 1–5 mg/h (titrate) | 5–10 min | 2–4 h | Hypotension, histamine release, bronchospasm | Active metabolites accumulate in renal failure. Avoid in asthma/bronchospasm and shock. |
| Ketamine | 0.5–1 mg/kg | 0.5–2 mg/kg/h (sedation) 0.1–0.5 mg/kg/h (analgesic adjunct) | 30–60 s | 10–20 min | Hypertension, tachycardia, secretions, emergence phenomena | Good choice in hypotension and bronchospasm. Combine with an opioid. |
| Propofol | Usually no bolus in ED (or 0.25–0.5 mg/kg if stable) | 5–50 mcg/kg/min (0.3–3 mg/kg/h) | <1 min | 5–10 min | Hypotension, bradycardia, hypertriglyceridaemia; propofol infusion syndrome (high dose >48 h) | Avoid or use very low dose in shock. Not for prolonged sedation in children. |
| Midazolam | 1–2 mg (0.01–0.05 mg/kg) | 0.02–0.1 mg/kg/h | 2–5 min | 1–2 h | Hypotension, delirium, accumulation | Useful if propofol is not tolerated; associated with more delirium and longer ventilation. Accumulates in renal/hepatic failure and elderly. |
| Dexmedetomidine | No bolus (avoid loading in ED / unstable patients) | 0.2–1 mcg/kg/h (max 1.5) | 15–30 min | — | Bradycardia, hypotension | Light sedation and adjunct only; not adequate alone for deep sedation or a paralysed patient. |
Aim for light sedation (e.g. RASS −1 to −2) once stable, unless deep sedation is needed (e.g. persistent paralysis, severe ARDS, raised ICP). Obese patients: infusions are commonly dosed on ideal or adjusted body weight.
8Haemodynamic management
Recognition
- SBP <90 mmHg, MAP <65 mmHg, or a fall >20% from baseline; new bradycardia; rising lactate.
- Pre-intubation red flags: shock index ≥ 0.9, SBP <100, severe acidosis, RV failure.
Fluids
Give 250–500 mL crystalloid boluses only if hypovolaemic or fluid-responsive; reassess after each. Routine pre-intubation boluses have not been shown to reduce collapse in trial data. Avoid large volumes in cardiogenic shock or RV failure.
Vasopressors — common peri-intubation options
| Drug | Dose | Notes |
|---|---|---|
| Norepinephrine (infusion) | Start 0.05–0.1 mcg/kg/min (≈ 5–10 mcg/min), titrate to 0.5+ | First-line in most shock. Peripheral infusion via a good proximal cannula is acceptable short term — monitor the site. |
| Epinephrine (infusion) | 0.05–0.5 mcg/kg/min | Inotrope + vasopressor; useful in cardiogenic shock, bradycardia, anaphylaxis. |
| Push-dose epinephrine | 10–20 mcg IV every 2–5 min 10 mcg/mL syringe | Bridge only while an infusion starts. |
| Push-dose phenylephrine | 50–200 mcg IV every 2–5 min 100 mcg/mL syringe | Pure vasoconstrictor; may cause reflex bradycardia; avoid in poor LV function. |
| Vasopressin | 0.03–0.04 units/min | Adjunct in septic shock; useful in RV failure/pulmonary hypertension. |
| Dobutamine | 2.5–10 mcg/kg/min | Inotrope for low-output cardiogenic shock, with a vasopressor. |
When to start vasopressors
- Before induction if SBP <90 / MAP <65 or shock index ≥ 0.9 despite appropriate fluid — connect and run the infusion.
- Have push-dose drawn up for every high-risk RSI.
- Start immediately for post-intubation hypotension once tube position, pneumothorax and auto-PEEP have been checked.
9Ventilator starting settings
Volume-control assist-control is a reasonable default. Tidal volume is based on predicted body weight (PBW), never actual weight. PBW: male = 50 + 0.91 × (height cm − 152.4); female = 45.5 + 0.91 × (height cm − 152.4).
| Patient | Tidal volume | Rate | FiO₂ / SpO₂ target | PEEP | I:E | Pressure limit |
|---|---|---|---|---|---|---|
| Typical adult | 6–8 mL/kg PBW | 14–18 | Start 1.0 → titrate to SpO₂ 92–96% | 5 cmH₂O | 1:2 | Plateau ≤ 30 cmH₂O |
| COPD / asthma | 6–8 mL/kg PBW | 8–12 | COPD SpO₂ 88–92%; asthma 92–96% | 0–5 cmH₂O | 1:4–1:5 (high flow 60–80 L/min) | Plateau <30; measure auto-PEEP; permissive hypercapnia (pH >7.20) |
| ARDS / severe hypoxaemia | 6 mL/kg PBW (4–8) | 20–30 (≤35) | Start 1.0 → SpO₂ 88–95% | 10+ cmH₂O (standard low-tidal-volume FiO₂/PEEP table) | 1:1–1:2 | Plateau ≤ 30; driving pressure ≤ 15 |
| Obesity | 6–8 mL/kg PBW | 16–20 | Titrate to SpO₂ 92–96% | 8–12+ cmH₂O | 1:2 | Plateau may exceed 30 because of chest wall; keep driving pressure low; head-up |
10🚨 Failed intubation / can't intubate, can't oxygenate (CICO)
- After 3 + 1 laryngoscopy attempts.
- SpO₂ falling (e.g. <90–93%) — stop, reoxygenate first.
- No improvement after changing technique.
- Bleeding or swelling from attempts — each attempt worsens the next.
- Video vs direct: videolaryngoscopy improves first-attempt success in trial data and is the current default approach; keep direct laryngoscopy as backup (e.g. blood/vomit obscuring camera).
- Bougie / stylet: use a stylet with hyperangulated blades; bougie for grade 2b/3 views.
- Change operator, position or device rather than repeating the same attempt.
- Number of attempts: current airway-society guidance suggests 3 + 1 intubation attempts and up to 3 SGA attempts; another widely-used cognitive-aid framework allows up to 3 attempts at each of face mask, SGA and tube; other guidance sets no fixed number but stresses limiting attempts. Obstetric-specific guidance allows fewer attempts (2, +1 by an experienced colleague).
- Front-of-neck technique: most current guidance favours scalpel–bougie–tube; some guidance accepts cannula or needle techniques in trained hands. In children <~8 years, needle cricothyroidotomy is generally preferred.
- Sugammadex: reversing rocuronium may help in a cannot-intubate situation, but current guidance warns it is not a reliable rescue for CICO.
11Special populations
🧒 Paediatric patients — paediatric dosing (separate from adult)
| Drug | Paediatric dose | Notes |
|---|---|---|
| Ketamine | 1–2 mg/kg IV · IM 4–5 mg/kg | Preferred in many paediatric RSIs; preserves BP. |
| Etomidate | 0.3 mg/kg IV | Labelled ≥10 years; used off-label in younger children. Caution in sepsis. |
| Propofol | 1–2.5 mg/kg IV | Haemodynamically stable children only. |
| Rocuronium | 1–1.2 mg/kg IV | Preferred where succinylcholine risk is uncertain. |
| Succinylcholine | 2 mg/kg IV infants / small children · 1–2 mg/kg older children · IM 4 mg/kg (max 150 mg) | Boxed warning: undiagnosed myopathy can cause hyperkalaemic arrest — reserve for emergency airway. Bradycardia risk. |
| Atropine | 0.02 mg/kg IV (max single dose 0.5 mg) | For bradycardia; consider before succinylcholine in infants or before a second dose. |
| Fentanyl / midazolam (post-tube) | Fentanyl 1 mcg/kg; midazolam 0.05–0.1 mg/kg | Titrate; adolescents ≥ 40 kg generally follow adult dosing (not exceeding adult doses). |
- Tube size (cuffed): internal diameter = age/4 + 3.5 mm (uncuffed age/4 + 4). Oral depth (cm) = age/2 + 12, or 3 × tube ID.
- Children desaturate very quickly — apnoeic oxygenation, gentle BVM, and the most experienced operator.
- Use a length-based tape or weight estimate if weight is unknown; double-check every dose.
🤰 Pregnancy
- Rapid desaturation (reduced FRC, higher O₂ use); higher aspiration risk; airway oedema → smaller tube (6.0–7.0) and VL.
- Left uterine displacement or 15–30° left tilt from ~20 weeks; head-up preoxygenation.
- Standard induction and paralytic doses; reduce induction dose if haemodynamically unstable.
- Involve obstetrics and neonatology early. Obstetric-specific airway guidance: limit attempts (2, +1 by experienced colleague).
⚖️ Obesity
- Ramp (tragus level with sternal notch), head-up 25–30°, NIV or HFNO preoxygenation, apnoeic oxygenation. Expect desaturation in < 1–2 minutes.
- Ultrasound-mark the cricothyroid membrane before induction.
- Dosing weights (commonly cited; sources vary): propofol and other induction agents — lean body weight; succinylcholine — total body weight; rocuronium — ideal or lean body weight (lean body weight gives faster onset); sedation infusions — ideal or adjusted body weight; sugammadex — total body weight (label).
- Ventilate on predicted body weight with higher PEEP.
🫁 Severe asthma / COPD
- Maximise bronchodilators and NIV first; intubation is high risk.
- Ketamine induction; the largest tube possible (≥ 7.5–8.0).
- After intubation: low rate, long expiratory time, accept hypercapnia. Hypotension → disconnect, then reduce rate.
🧠 Traumatic brain injury
- Avoid hypoxia (SpO₂ <90%) and hypotension (keep SBP ≥ 100–110 mmHg; one episode worsens outcome).
- Ketamine or etomidate; avoid propofol unless BP robust. Optional fentanyl 1–3 mcg/kg pretreatment only if hypertensive and stable.
- Target PaCO₂ 35–40 mmHg (ETCO₂ ~35); head-up 30°; manual in-line stabilisation; avoid tight ETT ties.
🦠 Severe sepsis / shock
- Resuscitate before induction; norepinephrine running; push-dose ready.
- Reduced-dose ketamine or etomidate; full-dose rocuronium (hyperkalaemia, rhabdomyolysis or AKI often unknown).
- NIV preoxygenation; anticipate arrest and have CPR plan ready.
🌬️ Severe hypoxaemia
- NIV preoxygenation (trial-supported); BVM with PEEP between induction and laryngoscopy (trial-supported); apnoeic oxygenation.
- Most experienced operator, videolaryngoscope, first-pass focus. Consider delayed sequence with ketamine.
- After intubation: ARDS ventilation settings.
⚡ Hyperkalaemia
- Avoid succinylcholine — use rocuronium.
- Treat before or during RSI: IV calcium, insulin–dextrose, nebulised salbutamol (see EMOnCall Hyperkalaemia protocol).
- Avoid post-intubation hypoventilation — respiratory acidosis raises K⁺. Match pre-intubation minute ventilation.